Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „deferasirox“
Suchtreffer
Begriffe & Kennungen
Deferasirox Mylan · 4.8 · Creatinine clearance in transfusional iron overload
Eintrag öffnenDeferasirox Mylan · 4.8 · Description of selected adverse reactions
Eintrag öffnenDeferasirox Mylan · 4.8 · Diarrhoea is reported more commonly in paediatric patients aged 2 to 5 years than in older patients.
Eintrag öffnenDeferasirox Mylan · 4.8 · During clinical studies dose-dependent increases in serum creatinine occurred in about 36% of patients, though
Eintrag öffnenDeferasirox Mylan · 4.8 · Gallstones and related biliary disorders were reported in about 2% of patients. Elevations of liver transamina
Eintrag öffnenDeferasirox Mylan · 4.8 · In a 1-year study in patients with non-transfusion-dependent thalassaemia syndromes and iron overload (dispers
Eintrag öffnenDeferasirox Mylan · 4.8 · In a retrospective meta-analysis of 2,102 adult and paediatric beta-thalassaemia patients with transfusional i
Eintrag öffnenDeferasirox Mylan · 4.8 · In two clinical studies, growth and sexual development of paediatric patients treated with deferasirox for up
Eintrag öffnenDeferasirox Mylan · 4.8 · Paediatric population
Eintrag öffnenDeferasirox Mylan · 4.8 · Renal tubulopathy has been mainly reported in children and adolescents with beta-thalassaemia treated with def
Eintrag öffnenDeferasirox Mylan · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenDeferasirox Mylan · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenDeferasirox Mylan · 4.8 · Severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS), toxic epidermal necrolys
Eintrag öffnenDeferasirox Mylan · 4.8 · Summary of the safety profile
Eintrag öffnenDeferasirox Mylan · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenDeferasirox Mylan · 4.8 · The most frequent reactions reported during chronic treatment in clinical studies conducted with deferasirox d
Eintrag öffnenEnyglid · 4.5 · In an interaction study with healthy volunteers, co-administration of deferasirox (30 mg/kg/day, 4 days), a mo
Eintrag öffnenExjade · 4.5 · Agents that may decrease EXJADE systemic exposure Deferasirox metabolism depends on UGT enzymes. In a healthy
Eintrag öffnenExjade · 4.5 · Agents that may decrease EXJADE systemic exposure Deferasirox metabolism depends on UGT enzymes. In a healthy
Eintrag öffnenExjade · 4.5 · Cholestyramine significantly reduced the deferasirox exposure in a mechanistic study to determine the degree o
Eintrag öffnen